| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_316daeca57d4c28b87f56cac56b6810e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-89 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B57-00 |
| filingDate |
2001-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2010-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_588019ceb169aaed020340fd8a6086ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168d3a842f09c26f5b3f1a9d6df3e526
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_733cdf129b74ba3adbc5a6e466676b0b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da10aa8d0ba6c4329c694a84b9e2a2a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8b2e57bc0929690f46b1cf672b9dc29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1faa2b2d8ee5f3dcdebaacaea0c94fe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bc54c6255ff2fae7aaa3354caf66e4e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6300449cfcaca3eb162f60143a0f62d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30ee02a96236e60efeda931b26f41bf0 |
| publicationDate |
2010-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2406266-C |
| titleOfInvention |
A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds |
| abstract |
The invention relates to N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxamidine and its optically active enantiomers. (R)-(-)-N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxamidine and (S)-(+)-N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxamidine. Furthermore, the invention relates to the preparation of N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboxyimidoyl chloride, which may be used as an active ingredient of medicaments, and the preparation of the optically active enantiomers of this compound using the compounds of the invention as intermediate substances. |
| priorityDate |
2000-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |